This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
A PACS is one of the most critical assets within a healthcare organization, housing sensitive patient records, diagnostic images, and other Protected Health Information (PHI). With the increasing prevalence of cyber threats and stringent regulations around data privacy, securing this information is more important than ever. While high-quality PACS are equipped with built-in security features that prevent unauthorized access and data breaches, there are additional steps organizations can take to
F-18 fluorothymidine (FLT) PET can identify early acute gastrointestinal graft versus host disease (GVHD) after patients undergo bone marrow transplants, according to a study published December 13 in Radiology: Imaging Cancer. The finding is from a clinical trial in patients with blood cancers and suggests the method can locate specific areas of the disease that are difficult to biopsy, noted lead authors Jennifer Holter-Chakrabarty, MD, and Lacey McNally, PhD, of the University of Oklahoma Heal
There are several strategies for the early detection of prostate cancer. The first step is often a blood test for prostate-specific antigen (PSA). If PSA levels exceed a certain threshold, the next step typically involves taking a tissue sample for analysis. Another option is to use magnetic resonance imaging (MRI) to search for signs of a tumor before deciding whether a biopsy is necessary, reserving biopsies only for cases where abnormalities are detected.
It is because doctors are understood to place patients interests above commercial ones that they have long enjoyed professional autonomy and public trust. The history of medicine is too littered with incompetence and immorality to believe that doctors have always been worthy of this status. Still, something profound is lost when we submit to the jaundiced view that medicine is a business like any other.
Amidst rising cancer prevalence and soaring costs, new cancer technologies and innovations are emerging to support the early detection, treatment, and surveillance of cancer. Read this guide to understand how to evaluate these solutions for your employees and members – and to learn more about the current state of coverage, clinical and cost effectiveness, and impact on quality and outcomes.
With this signal about the publics preference for notification, the question for health systems and policymakers is not whether to notify patients but when and how.
While COVID and radiology salaries hit the top of AuntMinnie.com's Top 10 most-read posts in 2023, they rounded out the bottom of this year's list. Instead, the AuntMinniecommunity gravitated more toward articles describing how advanced image analysis -- including AI-based assessment of body composition on CT scans -- can track treatment results and predict patient outcomes.
While COVID and radiology salaries hit the top of AuntMinnie.com's Top 10 most-read posts in 2023, they rounded out the bottom of this year's list. Instead, the AuntMinniecommunity gravitated more toward articles describing how advanced image analysis -- including AI-based assessment of body composition on CT scans -- can track treatment results and predict patient outcomes.
Infertility affects an estimated 186 million people worldwide, with fallopian tube obstruction contributing to 11%-67% of female infertility cases. Researchers have developed an innovative solution using a magnetically driven robotic microscrew to treat fallopian tube blockages. The microrobot is made from nonmagnetic photosensitive resin, coated with a thin iron layer to give it magnetic properties.
Every business in the country has to evaluate its obligation to comply with the Corporate Transparency Act (CTA) by December 31, 2024. The CTA was enacted as part of the Federal Anti-Money Laundering Act of 2020, and the regulations became effective on January 1, 2024. Many practices may already have complied with the law by either submitting the required information or by determining that they are exempt from filing.
Patient-centric scheduling can only be achieved through optimized radiology workflows, effective communications between staff and physicians, and, of course, through specialized schedulers. In this guide, we’ll take you through a step-by-step process to transform your radiology center into a high-performance hub of medical imaging.
More than 100 plaintiffs have now sued the Marlborough, Massachusetts-based mammography-maker, claiming they suffered injuries and emotional distress stemming from implantation of the BioZorb radiographic marker.
Every business in the country has to evaluate its obligation to comply with the Corporate Transparency Act (CTA) by December 31, 2024. The CTA was enacted as part of the Federal Anti-Money Laundering Act of 2020, and the regulations became effective on January 1, 2024. Many practices may already have complied with the law by either submitting the required information or by determining that they are exempt from filing.
New findings indicate as many as 96% of men with positive PSA labs who show insignificant or slow-growing cancer on MRI can safely forego biopsy for three or more years.
The U.S. Food and Drug Administration (FDA) has issued a recall of Hologics BioZorb 3D bioabsorbable radiographic markers, with 252 injuries reported to date. The recall follows a warning by the FDA to consumers, healthcare providers, and healthcare facilities not to use the markers as well as a voluntary recall by Hologic, both issued in October. This recall involves removing the devices from where they are used or sold, as the devices may cause serious injury or death with continued use, the F
About 40% of us will be diagnosed with cancer in our lifetime, and patients are getting younger. At the same time, the cost of treatment continues to rise, with employers spending 8.5% more on cancer care for each employee than they did last year. The best thing employers can do for their employees and business tomorrow is to invest in cancer detection and care today.
The European Radiology Private Foundation andthe Editor in Chief of European Radiology , Prof. Bernd Hamm, are delighted to announce the recipients of the prestigious Albert L. Baert Editorial Fellowship for 2025, Dr. Mohamed El-Diasty and Dr. Pablo Rodrguez Carnero ! The selected candidates will embark on their fellowship journey with an introductory in-person meeting with the Editor in Chief at ECR 2025, where they will gain some first insights into European Radiology and manuscript handling.
Society of Nuclear Medicine and Molecular Imaging President, Cathy Cutler, explains the long road to jump-starting a new U.S. domestic supply of imaging isotopes.
Siemens Healthineers company Varian has received clearance from the U.S. Food and Drug Administration (FDA) to sell the latest version of its radiotherapy technology, RapidArc Dynamic. RapidArc Dynamic is available as an optional feature for the latest version of Eclipse treatment planning software on the TrueBeam 4.1 radiotherapy delivery platform, Varian said.
Discover how Color's comprehensive care solution is revolutionizing cancer screening adherence and knowledge. Through an in-depth case study, Color's unique approach to comprehensive cancer care has shown significant benefits in increasing screening rates and enhancing patient knowledge. Participants reported a 2-3x increase in adherence to screening guidelines over just 8 weeks, with 84% of participants increasing their familiarity with timing and frequency of cancer screening.
tim.hodson Thu, 12/19/2024 - 11:54 Computed tomography (CT) has long been a cornerstone of modern imaging, providing detailed 3D insights into the human body and other materials. However, conventional CT requires hundreds of X-ray projections from multiple angles, exposing patients to significant radiation doses and relying on large, immobile systems.
Portable MRI developer Hyperfine has signed agreements with distributors to support commercial expansion plans of the Swoop portable MRI system into Turkey, Israel, and Saudi Arabia. The new distribution deals add to agreements established earlier in 2024 targeting future expansion across 13 European markets, India, Malaysia, and Indonesia. Hyperfine said the recent CE Mark for its ninth-generation AI-powered software, combined with the distribution network, positions the company for significant
Explore the latest insights from the American Cancer Society's “Cancer Statistics 2024” report, which unveils multiple alarming trends in cancer data. Cancer is on the rise among young adults, and diagnoses for 6 of the 10 most common cancers are escalating. With over 2 million new cancer cases projected in the U.S. this year, employers face increased challenges when it comes to supporting employees.
At the annual meeting of the Radiological Society of North America in Chicago, radiologists, technologists and assorted medical professionals from all around the country once again gathered to catch a glimpse of the latest technological breakthroughs in the radiology space. In the last couple years, artificial intelligence has garnered the most headlines, and with good reason.
The American Society of Radiologic Technologists (ASRT) has published results from its 2024 enrollment survey, showing that the number of new students enrolled increased compared with 2023. The ASRT highlighted the following findings: The number of enrolled radiography students increased from 17,679 students in 2023 entering American Registry of Radiologic Technologists (ARRT)-approved radiography programs to 19,815 in 2024.
As HR and Benefits leaders are in the midst of evaluating cancer care solutions and designing their requirements for vendors, it’s key to know what questions to ask to ensure the development of a truly comprehensive strategy: from prevention to diagnosis to treatment to survivorship. Getting to the right answers starts with asking the right questions: How can better access improve engagement?
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 5,000 users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
52 
Let's personalize your content